First synthesis of 2′-oxabicyclo[3.1.0]hexyl nucleosides with a north conformation

Tetrahedron

Volumn 66, Issue 9, 2010, Pages 1706-1715

  Kim, Won Hee ^a   Park, Ah Young ^a   Kang, Jin Ah ^a   Kim, Jungsu ^a   Kim, Jin Ah ^a   Lee, Hyung Rock ^a   Chun, Pusoon ^a   Choi, Jungwon ^b   Lee, Chong Kyo ^c   Jeong, Lak Shin ^d   Moon, Hyung Ryong ^a  

^a Pusan National University   (South Korea)

^b Suwon University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

Anomeric effect; North conformation; Oxabicyclo 3.1.0 hexyl nucleosides; X ray structure

Indexed keywords

5 (HYDROXYMETHYL) 3 OXABICYCLO[3.1.0]HEXAN 2 YL) 5 METHYLPYRIMIDINE 2,4 (1H,3H) DIONE; 5 (HYDROXYMETHYL) 3 OXABICYCLO[3.1.0]HEXAN 2 YL)PYRIMIDINE 2,4 (1H,3H) DIONE; ACETIC ACID; ANTIVIRUS AGENT; EPICHLOROHYDRIN; NUCLEIC ACID BASE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DESILYLATION; DRUG CONFORMATION; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LACTONIZATION; NONHUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 75149112252     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.01.014     Document Type: Article

References (37)

1. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., and Schaeffer H.J. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5716
2. Schaeffer H.J., Beauchamp L., de Miranda P., Elion G.B., Bauer D.J., and Collins P. Nature 272 (1978) 583
3. Vere Hodge R.A., and Cheng Y.C. Antiviral Chem. Chemother. 4 (1993) 13
4. Crooks R.J., and Murray A. Antiviral Chem. Chemother. 5 (1994) 3107
5. Field H.J. Expert Opin. Invest. Drugs 5 (1996) 925
6. Vere Hodge R.A. Antiviral Chem. Chemother. 4 (1993) 67
7. Spector S.A., McKinley G.F., Lalezari J.P., Samo T., Andruczk R., Follansbee S., Sparti P.D., Havlir D.V., Simpson G., Buhles W., Wong R., and Stempien M.J. N. Engl. J. Med. 334 (1996) 1491
8. Theodoridis A., Sivenas C., Vagena A., and Capetanakis J. Arch. Dermatol. Res. 262 (1978) 173
9. Spadari S., Ciarrocchi G., Focher F., Verri A., Maga G., Arcamone F., Iafrate E., Manzini S., Garbesi A., and Tondelli L. Mol. Pharmacol. 47 (1995) 1231
10. Haynes P., Lambert T.R., and Mitchell I. Mutat. Res., Genetic Toxicol. 369 (1996) 65
11. Fyfe J.A., Keller P.M., Furman P.A., Miller R.L., and Elion G.B. J. Biol. Chem. 253 (1978) 8721
12. De Clercq E. Adv. Virus Res. 42 (1993) 1
13. Marquez V.E., Siddiqui M.A., Ezzitouni A., Russ P., Wang J., Wagner R.W., and Matteucci M.D. J. Med. Chem. 39 (1996) 3739
14. Altona C., and Sundaralingam M. J. Am. Chem. Soc. 94 (1972) 8205
15. Zalah L., Huleihel M., Manor E., Konson A., Ford Jr. H., Marquez V.E., Johns D.G., and Agbaria R. Antiviral Res. 55 (2002) 63
16. Marquez V.E., Ben-Kasus T., Barchi Jr. J.J., Green K.M., Nicklaus M.C., and Agbaria R. J. Am. Chem. Soc. 126 (2004) 543
17. Nasr M., Litterst C., and McGowan J. Antiviral Res. 14 (1990) 125
18. De Clercq E. AIDS Res. Hum. Retroviruses 8 (1992) 119
19. Mitsuya H., and Broder S. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 1911
20. Hong J.H., Choi Y., Chun B.K., Lee K., and Chu C.K. Arch. Pharm. Res. 21 (1998) 89
21. Tai-Shun L., Schinazi R.F., and Prusoff W.H. Biochem.Pharmacol. 36 (1987) 2713
22. Hamamoto Y., Nakashima H., Matsui T., Matsuda A., Ueda T., and Yamamoto N. Antimicrob. Agents Chemother. 31 (1987) 907
23. Marquez V.E., Ezzitouni A., Russ P., Siddiqui M.A., Ford Jr. H., Feldman R.J., Mitsuya H., George C., and Barchi Jr. J.J. J. Am. Chem. Soc. 120 (1998) 2780
24. Choi Y., George C., Comin M.J., Barchi Jr. J.J., Kim H.S., Jacobson K.A., Balzarini J., Mitsuya H., Boyer P.L., Hughes S.H., and Marquez V.E. J. Med. Chem. 46 (2003) 3292
25. Park A.-Y., Moon H.R., Kim K.R., Chun M.W., and Jeong L.S. Org. Biomol. Chem. 4 (2006) 4065
26. Kim K.R., Park A.-Y., Lee H.-R., Kang J.-A., Kim W.H., Chun P., Bae J.H., Jeong L.S., and Moon H.R. Bull. Korean Chem. Soc. 29 (2008) 1977
27. Nakajima N., Horita K., Abe R., and Yonemitsu O. Tetrahedron Lett. 29 (1988) 4139
28. Bourgeois D., Craig D., Grellepois F., Mountford D.M., and Stewart A.J.W. Tetrahedron 62 (2006) 483
29. Deslongchamps P. In: Baldwin J.E. (Ed). Stereoelectronic Effect in Organic Chemistry (1983), Pergamon, Oxford
30. Thibaudeau C., Acharya P., and Chattopadhyaya J. Stereoelectronic Effects in Nucleosides & Nucleotides and their Structural Implications (2005), Uppsala University Press, Uppsala-Sweden
31. Vorbruggen H., and Ruh-Pohlenz C. In: Overman L.E. (Ed). Handbook of Nucleoside Synthesis (2001), John Wiley & Sons, New York, NY
32. Yoshimura Y., Watanabe M., Satoh H., Ashida N., Ijichi K., Sakata S., Machida H., and Matsuda A. J. Med. Chem. 40 (1997) 2177
33. Rousseau R.J., Robins R.K., and Townsend L.B. J. Am. Chem. Soc. 90 (1968) 2661
34. SMART and SAINT. Area Detector Software Package and SAX Area Detector Integration Program (1997), Bruker Analytical X-Ray, Madison, WI, USA
35. SADABS. Area Detector Absorption Correction Program (1997), Bruker Analytical X-Ray, Madison, WI, USA
36. Sheldrick G.M. Acta Crystallogr. A46 (1990) 467
37. Sheldrick G.M. SHELXL-97, Program for the Solution and Refinement of Crystal Structure (1997), University of Gottingen, Germany